Morgan Stanley
RENE

Morgan Stanley’s Cartesian Growth Corp II RENE Stock Holding History

Morgan Stanley’s Portfolio RENE Stock Details RENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19
Closed -$226 – 8243
2025
Q1 		$226 Buy
+19
New +$223 ﹤0.01% 7461

Other funds holding RENE

MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
CA
Crossingbridge Advisors Pleasantville, New York $567M AUM 0.34% 1-Year Est. Return

Morgan Stanley's RENE Position: Q2 2025 in Review

Morgan Stanley sold out of Cartesian Growth Corp II (RENE) in Q2 2025, closing a stake of 19 shares — an estimated $226 sold.

Morgan Stanley first reported a position in RENE in Q1 2025 and held it in 1 quarter. The position peaked at $226 in Q1 2025. 4 funds tracked by Wall St. Rank hold RENE as of Q2 2025.

  • Morgan Stanley reported no remaining Cartesian Growth Corp II position as of Q2 2025 after selling out during the quarter.
  • Morgan Stanley sold 19 Cartesian Growth Corp II shares in Q2 2025, an estimated $226.
  • Morgan Stanley first reported a position in Cartesian Growth Corp II in Q1 2025 and held it in 1 quarter.
  • Morgan Stanley's Cartesian Growth Corp II position peaked at $226 in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q2 2025.

Based on Morgan Stanley's 13F filing for Q2 2025, filed 15 Aug 2025.